Regulation of NRF2 by Phosphoinositides and Small Heat Shock Proteins

Abstract

Reactive oxygen species (ROS) are generated by aerobic metabolism, and their deleterious effects are buffered by the cellular antioxidant response, which prevents oxidative stress. The nuclear factor erythroid 2-related factor 2 (NRF2) is a master transcriptional regulator of the antioxidant response. Basal levels of NRF2 are kept low by ubiquitin-dependent degradation of NRF2 by E3 ligases, including the Kelch-like ECH-associated protein 1 (KEAP1). Here, we show that the stability and function of NRF2 is regulated by the type I phosphatidylinositol phosphate kinase {gamma} (PIPKI{gamma}), which binds NRF2 and transfers its product phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) to NRF2. PtdIns(4,5)P2 binding recruits the small heat shock protein HSP27 to the complex. Silencing PIPKI{gamma} or HSP27 destabilizes NRF2, reduces expression of its target gene HO-1, and sensitizes cells to oxidative stress. These data demonstrate an unexpected role of phosphoinositides and HSP27 in regulating NRF2 and point to PIPKI{gamma} and HSP27 as drug targets to destabilize NRF2 in cancer. In briefPhosphoinositides are coupled to NRF2 by PIPKI{gamma}, and HSP27 is recruited and stabilizes NRF2, promoting stress-resistance.